These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30528822)

  • 1. Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia.
    Wang H; Xu Z; Lee BH; Vu S; Hu L; Lee M; Bu D; Cao X; Hwang S; Yang Y; Zheng J; Lin Z
    J Invest Dermatol; 2019 May; 139(5):1089-1097. PubMed ID: 30528822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progressive symmetric erythrokeratodermia: Activating mutations of TRPM4].
    Dereure O
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):600-601. PubMed ID: 31358308
    [No Abstract]   [Full Text] [Related]  

  • 3. Gain-of-function of TRPM4 predisposes mice to psoriasiform dermatitis.
    Yamada D; Vu S; Wu X; Shi Z; Morris D; Bloomstein JD; Huynh M; Zheng J; Hwang ST
    Front Immunol; 2022; 13():1025499. PubMed ID: 36341417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive progressive symmetric erythrokeratoderma results from a homozygous loss-of-function mutation of
    Shah K; Ansar M; Mughal ZU; Khan FS; Ahmad W; Ferrara TM; Spritz RA
    J Med Genet; 2017 Mar; 54(3):186-189. PubMed ID: 27965375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negatively charged amino acids near and in transient receptor potential (TRP) domain of TRPM4 channel are one determinant of its Ca2+ sensitivity.
    Yamaguchi S; Tanimoto A; Otsuguro K; Hibino H; Ito S
    J Biol Chem; 2014 Dec; 289(51):35265-82. PubMed ID: 25378404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incompletely penetrant TRPM4-associated progressive symmetric erythrokeratodermia responses to methotrexate.
    Jiang X; Wang Z; Lin Z; Xu Z; Wang H
    J Dermatol; 2022 Nov; 49(11):e422-e423. PubMed ID: 35796031
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrant Deactivation-Induced Gain of Function in TRPM4 Mutant Is Associated with Human Cardiac Conduction Block.
    Xian W; Hui X; Tian Q; Wang H; Moretti A; Laugwitz KL; Flockerzi V; Ruppenthal S; Lipp P
    Cell Rep; 2018 Jul; 24(3):724-731. PubMed ID: 30021168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.
    Kruse M; Schulze-Bahr E; Corfield V; Beckmann A; Stallmeyer B; Kurtbay G; Ohmert I; Schulze-Bahr E; Brink P; Pongs O
    J Clin Invest; 2009 Sep; 119(9):2737-44. PubMed ID: 19726882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing Identifies a Novel
    Dong Y; Du R; Fan LL; Jin JY; Huang H; Chen YQ; Bi DD; Xiang R
    Biomed Res Int; 2021; 2021():9247541. PubMed ID: 33959666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial erythrokeratodermia variabilis with pustular lesions: a new variant?
    Zhang L; Huo W; Gao XH; Ma L; Xiu Y; Zheng S; Hong Y; Chen HD
    Acta Derm Venereol; 2010 May; 90(3):274-8. PubMed ID: 20526545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis.
    Liu H; Liu H; Fu XA; Yu YX; Zhou GZ; Lu XM; Tian HQ; Yu CP; Shi ZX; Yu ML; Zhang FR
    J Dermatol; 2012 Apr; 39(4):400-1. PubMed ID: 21950330
    [No Abstract]   [Full Text] [Related]  

  • 12. Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies.
    Amarouch MY; El Hilaly J
    Cardiovasc Ther; 2020; 2020():6615038. PubMed ID: 33381229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
    Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
    Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying
    Hotz A; Fölster-Holst R; Oji V; Bourrat E; Frank J; Marrakchi S; Ennouri M; Wankner L; Komlosi K; Alter S; Fischer J
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis.
    Sbidian E; Bousseloua N; Jonard L; Leclerc-Mercier S; Bodemer C; Hadj-Rabia S
    Acta Derm Venereol; 2013 Mar; 93(2):193-5. PubMed ID: 23037955
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis.
    Charfeddine C; Laroussi N; Mkaouar R; Jouini R; Khayat O; Redissi A; Mosbah A; Dallali H; Chedly Debbiche A; Zaouak A; Fenniche S; Abdelhak S; Hammami-Ghorbel H
    PLoS One; 2021; 16(10):e0258777. PubMed ID: 34669720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.
    Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E
    Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva.
    Dai S; Wang H; Lin Z
    Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient receptor potential melastatin 4 cation channel in pediatric heart block.
    Tian J; An XJ; Fu MY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(4 Suppl):79-84. PubMed ID: 29165759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate.
    Nilius B; Mahieu F; Prenen J; Janssens A; Owsianik G; Vennekens R; Voets T
    EMBO J; 2006 Feb; 25(3):467-78. PubMed ID: 16424899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.